Holen Sie sich die Stockscreener-App
22.25
4.76%
1.01
Schlusskurs vom Vortag:
$21.24
Offen:
$21.64
24-Stunden-Volumen:
8.23M
Relative Volume:
1.19
Marktkapitalisierung:
$11.06B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
55.62
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+5.50%
1M Leistung:
+2.91%
6M Leistung:
+76.31%
1J Leistung:
+66.04%
1-Tages-Spanne:
$21.44
$22.29
1-Wochen-Bereich:
$20.95
$22.29
52-Wochen-Spanne:
$8.02
$23.09
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.25 | 10.55B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco (ELAN) Gains FDA Emergency Use Authorization for Credelio CAT - GuruFocus
Elanco (ELAN) Upgraded to Overweight, Targets $27 Per Share - GuruFocus
Elanco (ELAN) Gains FDA Emergency Use Approval for Cat Treatment - GuruFocus
Elanco stock rises after FDA emergency authorization for cat screwworm treatment - Investing.com Canada
Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats - Reuters
Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space - Seeking Alpha
Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats – Company AnnouncementFT.com - Financial Times
Elanco Animal Health Stock Is Undervalued: AnalystElanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health rises as KeyBanc joins bull camp - TradingView
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarks2025 Sector Review & Low Risk High Reward Ideas - newser.com
How Elanco Animal Health Incorporated stock moves on employment dataJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Keybanc Initiates Coverage on ELAN with Overweight Rating and $2 - GuruFocus
KeyBanc initiates Elanco Animal Health stock with Overweight rating By Investing.com - Investing.com Canada
Elanco to Participate in the Upcoming Investor Conferences - Finviz
Elanco (ELAN) Receives Overweight Rating with Promising Growth P - GuruFocus
Elanco Animal Health (ELAN): Evaluating Valuation After Strong Q3 Earnings and Bullish Analyst Upgrades - Yahoo Finance
Can Elanco Animal Health Incorporated stock weather global recessionEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Elanco Animal Health (NYSE:ELAN) Upgraded by Argus to "Buy" Rating - MarketBeat
Elanco (NYSE: ELAN) to Join Evercore, Piper Sandler Investor Conferences Dec 3–4 - Stock Titan
Primecap Management Co. CA Buys 1,543,279 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Can Elanco Animal Health Incorporated stock deliver surprise earnings beatJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Is Elanco Animal Health Incorporated (5EA) stock a momentum leaderLayoff News & Stock Timing and Entry Methods - newser.com
Is Elanco Animal Health Incorporated stock positioned for secular growthWeekly Profit Recap & AI Driven Price Predictions - newser.com
Will Elanco Animal Health Incorporated stock benefit from sector leadershipInflation Watch & Consistent Return Investment Signals - newser.com
How Elanco Animal Health Incorporated stock reacts to global recession fearsJuly 2025 Closing Moves & Weekly Setup with ROI Potential - newser.com
Can Elanco Animal Health Incorporated stock surprise with earnings upsideEntry Point & High Conviction Trade Alerts - newser.com
Will Elanco Animal Health Incorporated stock deliver better than expected guidanceMarket Volume Report & AI Enhanced Trading Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from Fed rate cuts2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com
What to expect from Elanco Animal Health Incorporated in the next 30 days2025 Market Overview & Breakout Confirmation Alerts - newser.com
Argus reiterates buy rating on Elanco Animal Health stock, maintains $25 target By Investing.com - Investing.com South Africa
Will Elanco Animal Health Incorporated (5EA) stock hit Wall Street targetsInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
Argus reiterates buy rating on Elanco Animal Health stock, maintains $25 target - Investing.com Canada
Will Elanco Animal Health Incorporated (5EA) stock keep raising dividendsGap Down & Low Risk Growth Stock Ideas - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-11-19 15:40:18 - newser.com
Published on: 2025-11-19 14:41:06 - newser.com
Will Elanco Animal Health Incorporated (5EA) stock boost dividends further - newser.com
Published on: 2025-11-19 13:29:17 - newser.com
Will Elanco Animal Health Incorporated stock beat international competitionVolume Spike & Long-Term Safe Investment Plans - newser.com
Published on: 2025-11-19 11:13:26 - newser.com
Elanco Animal Health Incorporat (ELAN) Stock Forecasts - Yahoo! Finance Canada
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):